Abstract
Background
Endoscopy could help detect early gastric cancer (EGC) and improve the prognosis of patients. The aim of this study was to analyze the impact of endoscopy and endoscopic surveillance on the early detection of gastric cancer (GC), GC staging, and treatment selection.
Methods
Patients with GC diagnosed at our center from 2010 to 2022 were retrospectively analyzed and allocated to the short-interval group (had received endoscopy within 3 years before diagnosis), the long-interval group (had received endoscopy more than 3 years before diagnosis), and the unchecked group (had not received endoscopy before diagnosis). The differences in GC staging and treatment modalities among the three groups were analyzed, and the differences in the clinical and pathological features of EGC were further analyzed.
Results
One thousand and twenty-five GC patients were included, with 395 cases of EGC and 630 cases of advanced GC. The proportions of EGC in the short-interval, long-interval, and unchecked groups were 98.0%, 84.2%, and 29.8%, respectively (p < 0.001). Among the 387 lesions of 367 EGC patients were resected by endoscopic submucosal dissection (ESD), 341 (88.1%) exhibited curative resection, and 46 (11.9%) involved noncurative resections. Lesions of EGC differed significantly in diameter, depth of invasion, and curative resection rate (p = 0.033, 0.019, and 0.005, respectively). In the short-interval group, 87.8% of the lesions were ≤ 2 cm, 95.6% of the invasion depths were confined to the mucosal layer, and 96.7% of the eCura scores were A or B. Compared with the unchecked group, they had smaller diameters (RR = 0.419, 95% CI 0.234–0.752), shallower invasion depths (RR = 0.286, 95% CI 0.105–0.777), and a higher curative resection rate (RR = 0.215, 95% CI 0.068–0.676).
Conclusion
Endoscopic surveillance at 3-year intervals can help detect EGC, and the EGC lesions found have smaller diameters and shallower depths of invasion, helping improve the curative resection rate of ESD.
Graphical abstract
Similar content being viewed by others
References
Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Xia C, Dong X, Li H et al (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J 135(05):584–590
Yang L, Ying X, Liu S et al (2020) Gastric cancer: epidemiology, risk factors and prevention strategies. Chin J Cancer Res 32(6):695
Machlowska J, Maciejewski R, Sitarz R (2018) The pattern of signatures in gastric cancer prognosis. Int J Mol Sci 19(6):1658
Allemani C, Matsuda T, Di Carlo V et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet 391(10125):1023–1075
Hasuike N, Ono H, Boku N et al (2018) Gastrointestinal Endoscopy Group of Japan Clinical Oncology Group (JCOG-GIESG). A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607). Gastric Cancer 21(1):114–123
Zhang X, Li M, Chen S et al (2018) Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review. Gastroenterology 155(2):347–354
Charvat H, Sasazuki S, Inoue M et al (2016) Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II. Int J Cancer 138(2):320–331
Hamashima C, Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines (2018) Update version of the Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 48(7):673–683
Noh CK, Lee E, Lee GH et al (2021) Association of regular endoscopic screening with interval gastric cancer incidence in the National Cancer Screening Program. J Clin Med 11(1):230
Chen R, Liu Y, Song G et al (2021) Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut 70(2):251–260
Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14(2):101–112
Ono H, Yao K, Fujishiro M et al (2015) Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc 28(1):3–15
Ono H, Yao K, Fujishiro M et al (2021) Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc 33(1):4–20
Sugano K, Moss SF, Kuipers EJ (2023) Gastric intestinal metaplasia: real culprit or innocent bystander as a precancerous condition for gastric cancer? Gastroenterology 165(6):1352–1366.e1
Griniatsos J, Trafalis D (2018) Differences in gastric cancer surgery outcome between East and West: differences in surgery or different diseases? J BUON 23(5):1210–1215
Assumpção PP, Barra WF, Ishak G et al (2020) The diffuse-type gastric cancer epidemiology enigma. BMC Gastroenterol 20(1):223
Nam JH, Choi IJ, Cho SJ et al (2012) Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence. Cancer 118(20):4953–4960
Whiting JL, Sigurdsson A, Rowlands DC et al (2002) The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 50(3):378–381
Morii Y, Arita T, Shimoda K et al (2001) Effect of periodic endoscopy for gastric cancer on early detection and improvement of survival. Gastric Cancer 4:132–136
Jin S, Jeon SW, Kwon Y et al (2018) Optimal endoscopic screening interval for early detection of gastric cancer: a single-center study. J Korean Med Sci 33(23):e166
Pimentel-Nunes P, Libânio D, Marcos-Pinto R et al (2019) Management of epithelial precancerous conditions and lesions in the stomach (maps II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 51(04):365–388
Banks M, Graham D, Jansen M et al (2019) British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 68(9):1545–1575
Shah SC, Piazuelo MB, Kuipers EJ et al (2021) AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review. Gastroenterology 161(4):1325–1332
National Clinical Research Center for Digestive Disease (Shanghai), National Early Gastrointestinal-Center Prevention & Treatment Center Alliance, Helicobacter Pylori Group and Chinese Society of Gastroenterology et al (2020) Chinese consensus on management of gastric epithelial Chinese consensus on management of gastric epithelial precancerous conditions and lesions (2020). Chin J Dig 40(11):731–741
Sun L, Jin X, Huang L et al (2022) Risk of progression in patients with chronic atrophic gastritis: a retrospective study. Front Oncol 12:942091
Menon S, Trudgill N (2014) How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis. Endosc Int Open 2(2):E46–E50
Teh JL, Tan JR, Lau LJF et al (2015) Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol 13(3):480–487
Mommersteeg MC, Nieuwenburg SAV, den Hollander WJ et al (2021) Accuracy of upper endoscopies with random biopsies to identify patients with gastric premalignant lesions who can safely be exempt from surveillance. Gastric Cancer 24:680–690
Liu Q, Ding L, Qiu X et al (2020) Updated evaluation of endoscopic submucosal dissection versus surgery for early gastric cancer: a systematic review and meta-analysis. Int J Surg 73:28–41
Choi MK, Kim GH, Park DY et al (2013) Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center experience. Surg Endosc 27:4250–4258
Abe S, Takizawa K, Oda I et al (2021) Incidence and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer: Japan Clinical Oncology Group study—post hoc analysis of JCOG1009/1010. Gastric Cancer 24:1123–1130
Na YS, Kim SG, Cho SJ (2023) Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study. Gastric Cancer 26(2):298–306
Funding
This study was funded by “Pioneer” and “Leading Goose” R&D Program of Zhejiang (2023C03050) and Collaboration Program of Chinese Traditional and Modern Medicine in Gastric Cancer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Bin Lyu has been funded by “Pioneer” and “Leading Goose” R&D Program of Zhejiang (2023C03050) and Collaboration Program of Chinese Traditional and Modern Medicine in Gastric Cancer. Lu Sun, Yanjie Shen, Liang Huang, Jing Zhao, Meng Li, and Yue Hu have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sun, L., Shen, Y., Huang, L. et al. Impact of endoscopic surveillance on the early diagnosis and endoscopic resection likelihood of gastric cancer. Surg Endosc 38, 2188–2196 (2024). https://doi.org/10.1007/s00464-024-10748-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-024-10748-4